Bernard Doger S. U.
- Country
- Spain
- Department
- Phase I Clinical Trials Unit
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Hematologic Oncology
Focus on acute and chronic blood cancers treated in early‑phase studies.
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Chronic Lymphocytic Leukemia
- Diffuse Large B‑Cell Lymphoma
- Multiple Myeloma
Clinical investigations are conducted at a single Phase I unit in Madrid.
Advanced Solid Tumor Therapeutics
Evaluation of metastatic and refractory solid cancers across multiple organ systems.
- Non‑Small Cell Lung Cancer
- Colorectal Cancer
- Breast Cancer
- Pancreatic Ductal Adenocarcinoma
- Renal Cell Carcinoma
Trials include biomarker‑driven cohorts and novel targeted agents.
Immune‑Mediated Diseases
Targeted studies of inflammatory and autoimmune conditions.
- Severe Asthma
- Chronic Rhinosinusitis with Nasal Polyps
- Inflammatory Bowel Disease
- Multiple Sclerosis
- Hidradenitis Suppurativa
Research emphasizes novel biologics and pathway modulation.
Cardiovascular & Renal Therapeutics
Investigation of heart and kidney disorders with high clinical burden.
- Heart Failure with Reduced Ejection Fraction
- Chronic Kidney Disease
- Atherosclerotic Cardiovascular Disease
- Dilated Cardiomyopathy
- Acute Kidney Injury
Studies address both disease progression and organ‑protective strategies.
Infectious & Metabolic Research
Clinical evaluation of viral, bacterial and metabolic disorders.
- COVID‑19
- HIV Infection
- Alport Syndrome
- Autosomal Dominant Polycystic Kidney Disease
- Type 2 Diabetes Mellitus
Efforts include vaccine, antiviral and metabolic‑targeted interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.